Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mast cells and basophils are specialized granulocytes of the immune system that serve as key effectors in allergic and inflammatory responses (StatPearls, NBK470577). Mast cells are primarily tissue-resident, found in high concentrations at mucosal surfaces and the skin, while basophils are the least common granulocyte circulating in the blood (Nature Reviews Immunology, 2008). Both cell types express the high-affinity IgE receptor (FcεRI), which, when cross-linked by IgE-antigen complexes, triggers the release of preformed inflammatory mediators such as histamine, proteases, and heparin through a process called degranulation (JACI, 2015). This activation also leads to the synthesis of lipid mediators like leukotrienes and various pro-inflammatory cytokines, contributing to the pathophysiology of asthma, anaphylaxis, and chronic urticaria (}
Mast cell stabilization, inhibition of IgE binding to the high-affinity IgE receptor (FcεRI), and inhibition of KIT tyrosine kinase signaling (StatPearls, NBK554404; PubMed, 24507034).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mast cell and basophil (MC/B).